Literature DB >> 3527702

Effect of Bacteroides fragilis grown in the presence of clindamycin, metronidazole and fusidic acid on opsonization and killing of Escherichia coli.

F Namavar, J A Kaan, A M Verweij-van Vught, W A Vel, M Bal, A D Kester, D M MacLaren.   

Abstract

Bactericidal action of human polymorphonuclear leucocytes on Escherichia coli in the presence of Bacteroides fragilis grown in subinhibitory concentrations of clindamycin, metronidazole and fusidic acid was studied. Bacteroides fragilis grown in the absence of drugs significantly inhibited the killing of Escherichia coli. Bacteroides fragilis grown in the presence of the drugs had a reduced inhibitory effect on the killing of Escherichia coli but this reduction was only significant for Bacteroides fragilis grown in 1/2 MIC of clindamycin. The phagocytosis of Bacteroides fragilis grown with and without clindamycin, as measured by killing, was the same. Complement consumption of Bacteroides fragilis grown with and without clindamycin did not differ. Clindamycin-treated Bacteroides fragilis fixed C3 to a significantly lower degree than did untreated bacteria. The chemiluminescence of Escherichia coli opsonized with serum preincubated with clindamycin-treated Bacteroides fragilis was significantly higher than with serum preincubated with untreated bacteria. These results suggested that in killing experiments of mixed Escherichia coli and Bacteroides fragilis, the mechanism underlying the reduced inhibitory capacity of clindamycin-exposed Bacteroides fragilis is related to greater availability of C3 in serum for opsonization of Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3527702     DOI: 10.1007/bf02017790

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  24 in total

1.  Comparison of the biochemical properties of Bacteroides melaninogenicus from human dental plaque and other sites.

Authors:  H N Shah; R A Williams; G H Bowden; J M Hardie
Journal:  J Appl Bacteriol       Date:  1976-12

2.  Activity of metronidazole against Escherichia coli in experimental intra-abdominal sepsis.

Authors:  A B Onderdonk; T J Louie; F P Tally; J G Bartlett
Journal:  J Antimicrob Chemother       Date:  1979-03       Impact factor: 5.790

3.  Antibiotic-induced modification of Bacteroides fragilis and its susceptibility to phagocytosis by human polymorphonuclear leukocytes.

Authors:  C G Gemmell; P K Peterson; D Schmeling; J Mathews; P G Quie
Journal:  Eur J Clin Microbiol       Date:  1983-08       Impact factor: 3.267

4.  Phagocytosis and killing of bacteria in aerobic and anaerobic conditions.

Authors:  H R Ingham; P R Sisson; R L Middleton; H K Narang; A A Codd; J B Selkon
Journal:  J Med Microbiol       Date:  1981-11       Impact factor: 2.472

5.  The effect of capsular polysaccharide and lipopolysaccharide of Bacteroides fragilis on polymorph function and serum killing.

Authors:  J C Connolly; C McLean; S Tabaqchali
Journal:  J Med Microbiol       Date:  1984-06       Impact factor: 2.472

6.  Influence of bacterial-antibiotic interactions on subsequent antimicrobial activity of alveolar macrophages.

Authors:  W L Hand; N L King-Thompson; J D Johnson
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

7.  Clindamycin enhances opsonization of Staphylococcus aureus.

Authors:  D Milatovic; I Braveny; J Verhoef
Journal:  Antimicrob Agents Chemother       Date:  1983-09       Impact factor: 5.191

8.  Potentiation of opsonization and phagocytosis of Streptococcus pyogenes following growth in the presence of clindamycin.

Authors:  C G Gemmell; P K Peterson; D Schmeling; Y Kim; J Mathews; L Wannamaker; P G Quie
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

9.  Killing of Escherichia coli by human polymorphonuclear leucocytes in the presence of Bacteroides fragilis.

Authors:  W A Vel; F Namavar; A M Verweij-van Vught; A N Pubben; D M MacLaren
Journal:  J Clin Pathol       Date:  1985-01       Impact factor: 3.411

Review 10.  Pathogenic synergy: mixed intra-abdominal infections.

Authors:  D M MacLaren; F Namavar; A M Verweij-Van Vught; W A Vel; J A Kaan
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.